Dizal (Jiangsu) Pharmaceutical Co Ltd Class A 688192
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- ¥37.81
- Day Range
- ¥39.81–44.06
- 52-Week Range
- ¥24.82–54.58
- Bid/Ask
- ¥43.81 / ¥43.82
- Market Cap
- ¥18.21 Bil
- Volume/Avg
- 5.8 Mil / 1.7 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 52.69
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Dizal (Jiangsu) Pharmaceutical Co Ltd is engaged in the research and development, production and sales of innovative drugs.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Value
- Total Number of Employees
- 581
- Website
- http://www.dizalpharma.com
Comparables
Valuation
|
Metric
|
688192
|
300142
|
000919
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 65.42 | 58.45 |
Price/Book Value | 25.80 | 2.07 | 1.07 |
Price/Sales | 52.69 | 5.81 | 1.20 |
Price/Cash Flow | — | 18.10 | 15.61 |
Price/Earnings
688192
300142
000919
Financial Strength
|
Metric
|
688192
|
300142
|
000919
|
|---|---|---|---|
Quick Ratio | 1.69 | 2.51 | 3.28 |
Current Ratio | 1.87 | 2.94 | 3.61 |
Interest Coverage | −68.37 | 24.73 | 388.44 |
Quick Ratio
688192
300142
000919
Profitability
|
Metric
|
688192
|
300142
|
000919
|
|---|---|---|---|
Return on Assets (Normalized) | −61.83% | 1.93% | 1.25% |
Return on Equity (Normalized) | −107.62% | 3.16% | 1.83% |
Return on Invested Capital (Normalized) | −73.37% | 2.01% | 1.04% |
Return on Assets
688192
300142
000919
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Zgccybcm | Hglx | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Zdjfcvktlf | Qcbpt | $78.0 Bil | |||
| Haleon PLC ADR
HLN
| Hlpklfz | Qgzyg | $48.4 Bil | |||
| Viatris Inc
VTRS
| Nsfsxtd | Hwhl | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Mpcffzbt | Hryr | $13.5 Bil | |||
| Catalent Inc
CTLT
| Dhhxjqrq | Lftbdk | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Wccfmcc | Psqxj | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Zddfpwxzk | Dkyg | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Drfksscrt | Mjtjy | $2.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Hbctzld | Nknqt | $2.3 Bil |
United States